Teva Pharmaceuticals v. Weiser

• Court: Court of Appeals for the Tenth Circuit
• Decided: September 5, 2025
• Docket: 24-1035
• Status: Unpublished

Opinion

Appellate Case: 24-1035 Document: 44-1 Date Filed: 09/05/2025 Page: 1 FILED United States Court of Appeals UNITED STATES COURT OF APPEALS Tenth Circuit

FOR THE TENTH CIRCUIT September 5, 2025 _________________________________ Christopher M. Wolpert Clerk of Court TEVA PHARMACEUTICALS USA, INC.,

Plaintiff - Appellee, No. 24-1035 v. (D.C. No. 1:23-CV-02584-DDD-JPO) (D. Colo.) PHILIP J. WEISER, in his official capacity as Attorney General of the State of Colorado; PATRICIA A. EVACKO; ERIC FRAZER; RYAN LEYLAND; AVANI SONI; JAYANT PATEL; KRISTEN WOLF; ANDREA ZUCCARELLI, in their official capacity as members of the Colorado State Board of Pharmacy,

Defendants - Appellants. _________________________________

ORDER AND JUDGMENT* _________________________________

Before BACHARACH, BALDOCK, and CARSON, Circuit Judges. _________________________________

Epinephrine auto-injectors, commonly known as “EpiPens,” are lifesaving

medical devices that counter anaphylaxis, a potentially fatal allergic reaction. In 2023,

Colorado passed “An Act Concerning the Affordability of Epinephrine Auto-

Injectors.” H.B. 23-1002, 74th Gen. Assemb., Reg. Sess. (Co. 2023). The Colorado

* This order and judgment is not binding precedent, except under the doctrines of law of the case, res judicata, and collateral estoppel. It may be cited, however, for its persuasive value consistent with Fed. R. App. P. 32.1 and 10th Cir. R. 32.1. Appellate Case: 24-1035 Document: 44-1 Date Filed: 09/05/2025 Page: 2

Legislature declared, “approximately 565,824 individuals” in Colorado suffer from

“life-threatening food allergies,” but “[m]any individuals are unable to afford an

epinephrine auto-injector because they cannot pay the copayment amount required

under their insurance plan or, if they are uninsured, the cost of an epinephrine auto-

injector.” Id. § 1(d), (f). Consequently, the Legislature enacted the Colorado

epinephrine auto-injector affordability program “to provide low-cost epinephrine auto-

injectors to eligible individuals.” Colo. Rev. Stat. Ann. § 12-280-142(2). The program,

effective January 1, 2024, allegedly takes property from pharmaceutical manufacturers

without advance or contemporaneous compensation.

Plaintiff, Teva Pharmaceuticals, is a manufacturer of generic epinephrine auto-

injectors and is subject to Colorado’s affordability program. Ordinarily, Plaintiff sells

its auto-injectors to distributors and wholesalers for around $300 per two-pack.

Distributors and wholesalers then sell the auto-injectors to pharmacies at a marked-up

price, and consumers purchase the auto-injectors from these pharmacies. Colorado’s

affordability program modifies this commercial exchange by limiting how much a

pharmacy may charge qualifying uninsured individuals for a two-pack of epinephrine

auto-injectors to $60. Id. § 12-280-142(7). This means a pharmacy receives at most $60

for a product that cost it much more than that to supply. To offset the pharmacy’s loss,

the program shifts the financial burden to manufacturers like Plaintiff.

Under the program’s “reimburse or resupply” provision, pharmacies may recoup

their losses by submitting a claim for reimbursement of a dispensed auto-injector to

the manufacturer. Id. § 12-280-142(8)(a). The manufacturer then has a choice to either:

2 Appellate Case: 24-1035 Document: 44-1 Date Filed: 09/05/2025 Page: 3

“(I) Reimburse the pharmacy in an amount that the pharmacy paid for the number of

epinephrine auto-injectors dispensed through the program; or (II) Send the pharmacy a

replacement supply of epinephrine auto-injectors in an amount equal to the number of

epinephrine auto-injectors dispensed through the program.” Id. § 12-280-142(8)(c)(I–II).

In other words, the manufacturer must reimburse the pharmacy for the cost of the

dispensed auto-injectors or resupply them. Any manufacturer that fails to comply with

the reimburse or resupply requirement engages in a deceptive trade practice and is subject

to a fine. Id. § 12-280-142(11)(a).

Plaintiff brought suit against the Colorado Attorney General and individual

members of the Colorado State Board of Pharmacy in their official capacities. Plaintiff

alleges the Colorado affordability program’s reimburse or resupply requirement

violates the Fifth Amendment’s Takings Clause and seeks declaratory relief and an

injunction barring Defendants from enforcing the program’s reimburse or resupply

requirement. Defendants moved to dismiss the case, arguing, among other things, that

the Eleventh Amendment entitled Defendants to immunity from suit. The district court

held the Ex parte Young exception to Eleventh Amendment immunity applied and

denied their motion.1 See Ex parte Young, 209 U.S. 123, 159–60 (1908). The sole

question on appeal is whether Ex parte Young provides an exception to Defendants’

Eleventh Amendment immunity here. Verizon Maryland, Inc. v. Pub. Serv. Comm'n of

1 Plaintiff moved for a preliminary injunction. The district court denied Plaintiff’s motion but left open the possibility of awarding Plaintiff injunctive relief later should its remedy at law prove inadequate as the case develops. 3 Appellate Case: 24-1035 Document: 44-1 Date Filed: 09/05/2025 Page: 4

Maryland directs our inquiry into whether suit lies under Ex parte Young. 535 U.S. 635,

645 (2002). As Plaintiff’s complaint satisfies the Ex parte Young inquiry set forth in

Verizon, we exercise jurisdiction under 28 U.S.C. § 1291 via the collateral order

doctrine and affirm the district court’s denial of Defendants’ motion to dismiss based

on Eleventh Amendment immunity.

We review the denial of a motion to dismiss based on Eleventh Amendment

immunity de novo. Collins v. Daniels, 916 F.3d 1302, 1315 (10th Cir. 2019). The

Eleventh Amendment states, “[t]he Judicial power of the United States shall not be

construed to extend to any suit in law or equity, commenced or prosecuted against one

of the United States by Citizens of another State, or by Citizens or Subjects of any

Foreign State.” U.S. Const. amend XI. When applicable, the Eleventh Amendment

bars the exercise of federal subject matter jurisdiction. See Williams v. Utah Dep't of

Corr., 928 F.3d 1209, 1212 (10th Cir. 2019). The Eleventh Amendment “extends to

arms of the state and to state officials who are sued for damages in their official

capacity.” Id. It not only bars suits brought by “Citizens of another State” but also

“suits in federal court against a nonconsenting state brought by the state’s own

citizens.” Id. And as relevant here, Eleventh Amendment immunity generally extends

to claims arising under the Fifth Amendment’s Takings Clause “as long as a remedy is

available in state court.” 2 Id. at 1213.

2 Defendants argue that in Williams we held Ex parte Young does not extend to claims under the Fifth Amendment’s Takings Clause where a just compensation remedy exists in state court. 928 F.3d at 1212–14. But they misconstrue our precedent. In Williams, an inmate sued the Utah Department of Corrections (UDOC) and prison 4 Appellate Case: 24-1035 Document: 44-1 Date Filed: 09/05/2025 Page: 5

That said, “Eleventh Amendment immunity ‘is not absolute.’” Hendrickson v.

AFSCME Council 18, 992 F.3d 950, 965 (10th Cir. 2021) (quoting Port Auth. Trans-

Hudson Corp. v. Feeney, 495 U.S. 299, 304 (1990)). In Ex parte Young, the Supreme

Court recognized a narrow exception to Eleventh Amendment immunity “grounded in

traditional equity practice.” Whole Woman's Health v. Jackson, 595 U.S. 30, 39 (2021)

(citing Ex parte Young, 209 U.S. at 159–60). Ex parte Young “allows certain private

parties to seek judicial orders in federal court preventing state executive officials from

enforcing state laws that are contrary to federal law.” Id. “In determining whether the

doctrine of Ex parte Young avoids an Eleventh Amendment bar to suit, a court need only

conduct a straightforward inquiry into whether the complaint alleges an ongoing violation

of federal law and seeks relief properly characterized as prospective.” Verizon, 535 U.S.

at 645 (internal citation omitted).

Here, Plaintiff’s complaint easily satisfies the Ex parte Young exception to

Eleventh Amendment immunity under Verizon. Plaintiff alleges an ongoing violation

of federal law––that the affordability program’s reimburse or resupply requirement

officials claiming UDOC failed to pay prisoners interest earned on their prisoner funds in violation of the Takings Clause. Id. at 1211. We considered whether the Eleventh Amendment extended to takings claims and concluded it did “as long as a remedy is available in state court.” Id. at 1213. Defendants take this to mean Ex parte Young cannot apply where a remedy exists in state court. But that is far from what Williams says. We held the Eleventh Amendment extends to takings claims as long as a remedy exists in state court, not that the traditional exceptions to Eleventh Amendment immunity do not apply. Id. at 1213–15. Indeed, we separately considered whether Ex parte Young applied as an exception to the inmate’s suit and determined it did not under our “straightforward inquiry.” Id. at 1214–15. That inquiry does not consider the availability of a state forum. See Hill v. Kemp, 478 F.3d 1236, 1256 (10th Cir. 2007). 5 Appellate Case: 24-1035 Document: 44-1 Date Filed: 09/05/2025 Page: 6

violates the Fifth Amendment’s Takings Clause. And Plaintiff seeks relief properly

characterized as prospective––injunctive relief enjoining enforcement of the reimburse

or resupply requirement against Plaintiff. Ex parte Young requires no more. Id.

Defendants argue injunctive relief is never available for a takings plaintiff as

long as some remedy at law exists because compensation remedies are always adequate

in takings cases. But our straightforward Ex parte Young inquiry under Verizon does

not extend to an analysis of whether injunctive relief is available in a particular case.

“The inquiry into whether suit lies under Ex parte Young does not include an analysis

of the merits of the claim.” Id. at 636–37. It is instead enough that Plaintiff “seeks

relief properly characterized as prospective.” Id. (emphasis added). Id. at 645. “The

prayer for injunctive relief—that state officials be restrained from enforcing an order

in contravention of controlling federal law—clearly satisfies our ‘straightforward

inquiry.’” Id.

Nor does our analysis of whether the requested relief is “properly characterized

as prospective” invite inquiry into whether injunctive relief is ultimately available. See

id. at 645–46. Relief is not properly characterized as prospective if, in substance,

Plaintiff seeks retroactive relief, such as monetary damages resulting from a past

liability of the state. See Hill v. Kemp, 478 F.3d 1236, 1259 (10th Cir. 2007).

Consequently, we must evaluate whether the relief Plaintiff seeks is prospective “not

just in how it is captioned but also in its substance.” Id. But whether relief is “properly

characterized as prospective” is a separate question from whether injunctive relief is

warranted in a given case, and here, no question exists that Plaintiff seeks injunctive

6 Appellate Case: 24-1035 Document: 44-1 Date Filed: 09/05/2025 Page: 7

relief to prevent enforcement of an allegedly unconstitutional act. While a court may

not award injunctive relief unless no adequate remedy at law exists, Ex parte Young

allows Plaintiff to seek it.3

We AFFIRM the district court’s denial of Defendants’ motion to dismiss based

on Eleventh Amendment immunity and REMAND this case to the district court for

further proceedings consistent with this order and judgment.

Entered for the Court

Bobby R. Baldock Circuit Judge

3 Defendants argue the Sixth and Eighth Circuits consider the adequacy of legal remedies in their Ex parte Young analysis, pointing to Laborers' Int'l Union of N. Am., Loc. 860 v. Neff, 29 F. 4th 325 (6th Cir. 2022), Long v. Area Manager, Bureau of Reclamation, 236 F.3d 910 (8th Cir. 2001), and EEE Mins., LLC v. State of N. Dakota, 81 F.4th 809 (8th Cir. 2023). We are not convinced the Sixth Circuit conflated the adequacy of a legal remedy with its Ex parte Young analysis in Laborers' Int'l. 29 F.4th at 334–35. Rather, the court first explained Ex parte Young would allow the suit for injunctive relief to proceed before next addressing why injunctive relief was not available in that particular case. Id. To the extent the Eighth Circuit considers the availability of an adequate remedy at law within its Ex parte Young analysis, we depart from it in adherence to the Supreme Court’s directed “straightforward inquiry.” Verizon, 535 U.S. at 645. But we note the Eighth Circuit applied Ex parte Young after holding a state remedy at law inadequate in a takings case similar to this one. See Pharm. Rsch. & Manufacturers of Am. v. Williams, 64 F.4th 932, 950 (8th Cir. 2023). 7